Prasad Kothari
Papers
1
Total Citations
48
H-Index
1
About
Prasad Kothari is a leading oncologist whose research focuses on de-intensifying treatment for HPV-positive oropharyngeal cancer, a growing global concern among younger patients. His most cited work, a 2018 study, pioneered a paradigm shift by demonstrating that de-intensified adjuvant (chemo)radiotherapy after transoral minimally invasive surgery can maintain excellent outcomes while reducing long-term toxicity in resectable HPV-positive oropharyngeal carcinoma. This landmark contribution, cited 48 times, addresses the critical need to balance survival with quality of life, as HPV-positive patients often face decades of survivorship after standard chemoradiation. Kothari’s research has helped reshape clinical guidelines, offering a less aggressive yet equally effective alternative for this distinct patient population. His work underscores a broader commitment to precision oncology—tailoring therapy intensity to tumor biology rather than a one-size-fits-all approach. By challenging conventional treatment paradigms, Kothari has not only advanced the field of head and neck oncology but also improved the lived experience of patients navigating a cancer diagnosis at a relatively young age. His contributions continue to influence ongoing trials and clinical practice worldwide.
Research Focus
Key Achievements
Top Papers
- 1